跳至主要内容
临床试验/NCT06511323
NCT06511323尚未招募不适用

Evaluation of Brain Metastases Treated With Stereotactic Radiotherapy Using Dynamic [18F]FDG PET

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's0 个研究点目标入组 70 人开始时间: 2024年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
70
主要终点
Diagnostic accuracy of dynamic PET

研究概览

简要总结

The purpose of this study is to evaluate the clinical usefulness of dynamic [18F]FDG PET imaging in assessing brain metastasis post stereotactic radiotherapy to separate true progression from the treatment-related changes.

详细描述

After being informed about the study and potential risk, all participants giving written informed consent will be screened to determine if participant being referred fits eligibility criteria for the study, under of the supervision of the radiation oncologist. If a participant agrees to participate in this study, they will receive three additional imaging sessions (the dynamic PET scan). The first session will occur prior to starting treatment; the second session will occur at about 10 weeks post treatment; the third session will occur at first concern of progression at treated lesions or 12 months post-treatment, whichever comes earlier. These scans will be scheduled in addition to the participant's regular follow-up scans and appointments.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 or older.
  • Willing and able to provide consent.
  • Life expectancy ≥12 months.
  • Creatinine clearance ≥30 ml/min within 28 days prior to registration.
  • At the discretion of the treating oncologist, it is believed that at least 1 lesion (or resection cavity) is best managed with SRS/SFR

排除标准

  • Pregnant or nursing women.
  • Men or women of childbearing potential who are unwilling to employ adequate contraception.
  • Inability to complete a brain MRI.
  • Known allergy to gadolinium.
  • Inability to complete a PET scan.
  • Uncontrolled diabetes mellitus.
  • Primary germ cell tumour, primary CNS tumour, or lymphoma
  • SRS/FSRT is no longer indicated for any BMs
  • Must be able to read and write English

结局指标

主要结局

Diagnostic accuracy of dynamic PET

时间窗: 12-month follow-up.

Diagnostic accuracy will be calculated and compared based on the index lesion.

次要结局

  • Cost-effectiveness analysis(24-month follow-up)
  • Clinical outcomes(24-month follow-up)
  • Diagnostic imaging outcomes(24-month follow-up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Melody Qu

Radiation Oncologist

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

相似试验

Evaluation of Brain Metastases Treated With... | 临床试验